Literature DB >> 29896802

Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.

Eric Farfour1, Erwan Trochu1, Clotilde Devin1, Emilie Cardot Martin1, Lucie Limousin1, Antoine Roux2, Clément Picard2, Emilie Jolly1, Marc Vasse1, Philippe Lesprit1.   

Abstract

Entities:  

Keywords:  zzm321990Stenotrophomonas maltophiliazzm321990; Achromobacter spp; Burkholderia spp; ceftazidime avibactam; cystic fibrosis

Mesh:

Substances:

Year:  2018        PMID: 29896802     DOI: 10.1111/tid.12955

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


× No keyword cloud information.
  5 in total

1.  "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.

Authors:  Elise T Zeiser; Scott A Becka; Brigid M Wilson; Melissa D Barnes; John J LiPuma; Krisztina M Papp-Wallace
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 2.  Achromobacter Infections and Treatment Options.

Authors:  Burcu Isler; Timothy J Kidd; Adam G Stewart; Patrick Harris; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli.

Authors:  Scott A Becka; Elise T Zeiser; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

4.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

5.  Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.

Authors:  Qiuxia Lin; Hua Zou; Xian Chen; Menglu Wu; Deyu Ma; Hanbing Yu; Siqiang Niu; Shifeng Huang
Journal:  BMC Microbiol       Date:  2021-02-22       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.